Related Experiment Videos
Macrophage-inflammatory protein-1alpha regulates preosteoclast differentiation in vitro
B A Scheven1, J S Milne, I Hunter
1Skeletal Research Unit, Rowett Research Institute, Bucksburn, Aberdeen, Scotland, AB21 9SB, United Kingdom. B.Scheven@rri.sari.ac.uk
Biochemical and Biophysical Research Communications
|January 28, 1999
Summary
Macrophage inflammatory protein-1alpha (MIP-1alpha), a C-C chemokine, is crucial for osteoclast differentiation. Antibodies against MIP-1alpha inhibited osteoclast formation, suggesting its role in directing preosteoclast development and proliferation.
Area of Science:
- Bone Biology
- Cellular and Molecular Medicine
- Immunology
Background:
- Osteoclast differentiation is regulated by various growth factors.
- Fetal rat calvarial conditioned medium (RCCM) contains osteoclast-inducing growth factors (OGF).
- The specific identity and function of OGFs in bone resorption are not fully elucidated.
Purpose of the Study:
- To identify the specific OGFs within RCCM responsible for osteoclast differentiation.
- To investigate the role of macrophage inflammatory protein-1alpha (MIP-1alpha) in this process.
- To characterize the mechanism by which MIP-1alpha influences osteoclast precursor formation.
Main Methods:
- Utilized an in vitro system with RCCM to study osteoclastogenesis.
- Employed specific polyclonal antibodies against MIP-1alpha to assess its inhibitory effects.
- Performed reverse-phase HPLC and Western blotting to analyze RCCM composition and MIP-1alpha presence.
- Tested the bioactivity of recombinant rat MIP-1alpha on osteoclast precursor formation.
Main Results:
- Anti-MIP-1alpha antibodies significantly inhibited the development of TRAP-positive osteoclast precursors and multinucleated osteoclasts.
- MIP-1alpha antibody treatment increased macrophage-like cell numbers, indicating a role in directing preosteoclast formation and inhibiting proliferation.
- HPLC analysis revealed that heparin-binding OGF fractions, eluted at higher acetonitrile concentrations, were inhibited by anti-MIP-1alpha antibodies.
- Recombinant MIP-1alpha dose-dependently stimulated mononuclear osteoclast precursor formation, with maximal effect at 50 ng/ml.
Conclusions:
- Macrophage inflammatory protein-1alpha (MIP-1alpha) is identified as a key osteoclast-inducing growth factor in RCCM.
- MIP-1alpha plays a critical role in osteoclast differentiation and may regulate progenitor cell proliferation.
- Chemokines, specifically MIP-1alpha, are confirmed to be important in osteoclast recruitment and differentiation processes.